XML 122 R95.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value of Financial Instruments (Details-4) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]      
Beginning balance $ (26,456) $ (32,002) $ (42,026)
Realized and unrealized gains (losses):      
Included in regulatory asset 12,402 5,545 10,024
Included in other comprehensive income 0 0 0
Included in earnings [1] (6,439) (3,765) 132
Included in current assets (87) (70) (47)
Purchases 22,232 22,974 23,643
Sales 0 0 0
Issuances 0 0 0
Settlements (15,707) (19,138) (23,728)
Transfers in and/or out of Level 3 0 0 0
Ending balance $ (14,055) $ (26,456) $ (32,002)
[1] MGE's exchange-traded derivative contracts, over-the-counter party transactions, purchased power agreement, and FTRs are subject to regulatory deferral. These derivatives are therefore marked to fair value and are offset in the financial statements with a corresponding regulatory asset or liability.